Literature DB >> 16549276

Nucleus may be the key site of chloroquine antimalarial action and resistance development.

Gao-De Li1.   

Abstract

The first proposed hypothesis about the mechanism of chloroquine (CQ) action on malaria parasites is DNA intercalation hypothesis which indicates that the site of CQ action is within nucleus. Later on the interest of research was shifted from nucleus to lysosome due to the report of CQ accumulation within lysosome. The current opinions about CQ action and resistance are mainly based on the results of more than 30 years' studies on lysosome, which can be used to explain some facts but still remains incomplete and controversial. Based on recently published papers and our related data it is possible that the key CQ target protein may exist in nucleus. Development of CQ resistance is probably mainly due to the alteration in the CQ target protein or certain mechanism which prevents CQ from reaching its target protein in nucleus. In conclusion, the key site of CQ action may be in nucleus though it has not been well explored while CQ action in lysosome which has been well studied may be secondarily important in CQ action and resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16549276     DOI: 10.1016/j.mehy.2006.02.008

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

1.  Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.

Authors:  T S Skinner-Adams; K T Andrews; L Melville; J McCarthy; D L Gardiner
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

2.  The mechanism of antimalarial action of the ruthenium(II)-chloroquine complex [RuCl(2)(CQ)] (2).

Authors:  Alberto Martínez; Chandima S K Rajapakse; Becky Naoulou; Yasemin Kopkalli; Lesley Davenport; Roberto A Sánchez-Delgado
Journal:  J Biol Inorg Chem       Date:  2008-02-28       Impact factor: 3.358

Review 3.  Re-purposing Chloroquine for Glioblastoma: Potential Merits and Confounding Variables.

Authors:  Patrick Weyerhäuser; Sven R Kantelhardt; Ella L Kim
Journal:  Front Oncol       Date:  2018-08-27       Impact factor: 6.244

Review 4.  Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues.

Authors:  Ashutosh M Shukla; Aparna Wagle Shukla
Journal:  Drugs Context       Date:  2019-11-25

Review 5.  Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.

Authors:  Zi-Ning Lei; Zhuo-Xun Wu; Shaowei Dong; Dong-Hua Yang; Litu Zhang; Zunfu Ke; Chang Zou; Zhe-Sheng Chen
Journal:  Pharmacol Ther       Date:  2020-09-08       Impact factor: 12.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.